Press Releases

All ad hoc announcements pursuant to Art. 53 LR and press releases published by AEVIS VICTORIA SA can be downloaded here.

2011

AD HOC RELEASES PURSUANT TO ART. 53 LR

1
2
3
4

April 07, 2011 | 6:15 pm CEST

AD HOC RELEASES PURSUANT TO ART. 53 LR

Genolier Swiss Medical Network (GSMN): Offre publique d’achat de M.R.S.I. Medical Research, Services & Investments S.A. (MRSI)

April 06, 2011 | 11:48 pm CEST

AD HOC RELEASES PURSUANT TO ART. 53 LR

Genolier Swiss Medical Network (GSMN): Offre publique d’achat de M.R.S.I. Medical Research, Services & Investments S.A. (MRSI)

March 30, 2011 | 7:23 pm CEST

AD HOC RELEASES PURSUANT TO ART. 53 LR

Genolier Swiss Medical Network (GSMN): Offre publique d’achat de M.R.S.I. Medical Research, Services & Investments S.A. (MRSI)

March 23, 2011 | 7:45 pm CEST

AD HOC RELEASES PURSUANT TO ART. 53 LR

Genolier Swiss Medical Network (GSMN): Genolier Swiss Medical Network (GSMN): Offre publique d’achat de M.R.S.I. Medical Research, Services & Investments S.A.

March 23, 2011 | 5:35 pm CEST

AD HOC RELEASES PURSUANT TO ART. 53 LR

Genolier Swiss Medical Network (GSMN): Offre publique d’achat de M.R.S.I. Medical Research, Services & Investments S.A. (MRSI)

March 18, 2011 | 6:45 pm CEST

AD HOC RELEASES PURSUANT TO ART. 53 LR

Genolier Swiss Medical Network (GSMN): Offre publique d’achat de M.R.S.I. Medical Research, Services & Investments S.A. (MRSI)

February 28, 2011 | 7:15 am CEST

AD HOC RELEASES PURSUANT TO ART. 53 LR

Genolier Swiss Medical Network (GSMN): CHF 192.1 millions de Chiffre d’Affaires en 2010

February 10, 2011 | 7:30 pm CEST

AD HOC RELEASES PURSUANT TO ART. 53 LR

Genolier Swiss Medical Network (GSMN): Genolier Swiss Medical Network (GSMN): Dans le cadre de l’OPA Hubert-Reybier, GSMN publie ses résultats à fin septembre 2010

January 20, 2011 | 7:00 am CEST

AD HOC RELEASES PURSUANT TO ART. 53 LR

Genolier Swiss Medical Network SA (GSMN) takes note of the fact that the Hubert shareholder group intends to present a public offer of CHF 19 per share

1
2
3
4

OK

This website uses cookies.
Please see our Privacy Guidelines for further details.